WeVote
Log In

Bill

Bill

HR 3082

Evidence-Based Drug Policy Act of 2025

119th Congress Introduced by Ilhan Omar and 1 co-sponsor

The Evidence-Based Drug Policy Act of 2025 promotes effective drug treatment and prevention through research, funding, and training, improving outcomes for those with substance use disorders.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 3082

Summary of HR 3082: Evidence-Based Drug Policy Act of 2025

Purpose and Intent

The Evidence-Based Drug Policy Act of 2025 (HR 3082) aims to reform the current drug policy framework in the United States by emphasizing evidence-based practices in drug treatment, prevention, and enforcement. The bill seeks to address the ongoing challenges of substance abuse and the opioid crisis by promoting strategies that are proven to be effective through scientific research and data analysis.

Key Provisions

The bill includes several significant provisions designed to enhance the effectiveness of drug policy:

  1. Research and Data Collection:

    • Establishes a national database to collect and analyze data on drug use, treatment outcomes, and enforcement practices.
    • Allocates funding for research on the effectiveness of various drug treatment programs and prevention strategies.

  2. Funding for Treatment Programs:

    • Provides federal grants to states and local governments to implement evidence-based drug treatment programs.
    • Prioritizes funding for programs that focus on harm reduction, such as needle exchange programs and supervised consumption sites.

  3. Training and Resources:

    • Mandates training for law enforcement and healthcare professionals on evidence-based practices in drug treatment and prevention.
    • Offers resources for communities to develop tailored drug policy strategies based on local needs and conditions.

  4. Public Awareness Campaigns:

    • Authorizes the creation of public awareness campaigns aimed at educating the public about the risks of drug use and the benefits of treatment over incarceration.

  5. Evaluation and Accountability:

    • Requires regular evaluations of funded programs to assess their effectiveness and ensure accountability in the use of federal funds.

Affected Parties

The Evidence-Based Drug Policy Act of 2025 would impact various stakeholders, including:

  • Individuals struggling with substance use disorders: The bill aims to provide better access to effective treatment options.
  • Healthcare providers: Increased training and resources will enhance their ability to address substance use issues.
  • Law enforcement agencies: Training on evidence-based practices will shift focus from punitive measures to supportive interventions.
  • State and local governments: They will receive federal support to implement and evaluate new drug policies.

Procedural Aspects

  • Introduced Date: April 29, 2025
  • Current Status: The bill has been referred to the Committee on Oversight and Government Reform, as well as the Committees on Energy and Commerce and Judiciary for further consideration. The timeline for further action will be determined by the Speaker of the House.

Conclusion

HR 3082 represents a significant step towards reforming drug policy in the United States by prioritizing evidence-based approaches. If enacted, it could lead to improved outcomes for individuals affected by substance use disorders and a more effective allocation of resources in combating the drug crisis.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.